GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...

Trial finds weight loss drug taken monthly helps people lose 20% of body weight – but adverse GI events were ‘common’ - The ...

For instance, survivors with cancers related to obesity often face higher risks for cancer recurrence and death—not just from ...

Scientists created a new weight-loss drug that protects blood sugar levels and muscle mass. The new weight-loss tablet was ...

CagriSema is a once-weekly injection of semaglutide and cagrilintide. Clinical trial results for CagriSema showed significant improvements in A1C, weight loss, and time in range, marking it as a ...

He spotted the opportunity to invest in weight-loss drugs in 2023 before they exploded in 2024, and was an early AI mover, which he spied as a game changer in late 2022, early 2023. It’s all ...

In comparison, the average weight loss in the phase 3 clinical trials was 14.9% for once-weekly semaglutide 2.4 mg, 15.0% for tirzepatide 5 mg, and 20.9% for tirzepatide 15 mg.

suburbs to South Jersey and Delaware, what would you like WHYY News to cover? Let us know! Ever since blockbuster weight-loss drugs like Wegovy and Zepbound went mainstream, calls to local poison ...

Metsera has once again jolted the weight loss space with Phase I results from an ultra-long-acting amylin injectable showing weight loss of 8.4% at 36 days. The biotech’s shares rose as much as 20% on ...

Drugs that promise rapid and effortless weight loss once seemed like the stuff of fairytales. Now, even if we’re not “on the pen” ourselves, most of us know someone who is taking the much ...

Sandhagen (18-5 MMA, 11-4 UFC) has won four of his most recent five outings with the only loss to Umar Nurmagomedov. Dvalishvili, 34, successfully defends his title for the second time since he won it ...